nodes	percent_of_prediction	percent_of_DWPC	metapath
Epoprostenol—CYP2C9—Phentermine—obesity	0.0928	0.404	CbGbCtD
Epoprostenol—CYP2C9—Bupropion—obesity	0.0789	0.344	CbGbCtD
Epoprostenol—CYP2C9—Cimetidine—obesity	0.0579	0.252	CbGbCtD
Epoprostenol—PTGIS—gall bladder—obesity	0.0126	0.141	CbGeAlD
Epoprostenol—Treprostinil—PPARD—obesity	0.00816	0.714	CrCbGaD
Epoprostenol—PTGIS—respiratory system—obesity	0.00783	0.0874	CbGeAlD
Epoprostenol—PTGIR—hindbrain—obesity	0.00736	0.0822	CbGeAlD
Epoprostenol—PTGIS—cardiovascular system—obesity	0.006	0.067	CbGeAlD
Epoprostenol—P2RY12—cardiovascular system—obesity	0.0054	0.0603	CbGeAlD
Epoprostenol—PTGIS—adipose tissue—obesity	0.00529	0.0591	CbGeAlD
Epoprostenol—PTGIS—adrenal gland—obesity	0.00474	0.053	CbGeAlD
Epoprostenol—PTGIR—respiratory system—obesity	0.0045	0.0502	CbGeAlD
Epoprostenol—PTGIS—endocrine gland—obesity	0.00411	0.0459	CbGeAlD
Epoprostenol—PTGER1—endocrine gland—obesity	0.00382	0.0427	CbGeAlD
Epoprostenol—PTGIS—liver—obesity	0.00371	0.0414	CbGeAlD
Epoprostenol—P2RY12—endocrine gland—obesity	0.0037	0.0414	CbGeAlD
Epoprostenol—PTGIR—cardiovascular system—obesity	0.00344	0.0385	CbGeAlD
Epoprostenol—PTGIR—adipose tissue—obesity	0.00304	0.0339	CbGeAlD
Epoprostenol—PTGIR—digestive system—obesity	0.00286	0.0319	CbGeAlD
Epoprostenol—PTGIR—adrenal gland—obesity	0.00272	0.0304	CbGeAlD
Epoprostenol—PTGIR—endocrine gland—obesity	0.00236	0.0264	CbGeAlD
Epoprostenol—Bimatoprost—AKR1C3—obesity	0.00232	0.202	CrCbGaD
Epoprostenol—PTGIR—liver—obesity	0.00213	0.0238	CbGeAlD
Epoprostenol—CYP2C9—cardiovascular system—obesity	0.00123	0.0137	CbGeAlD
Epoprostenol—CYP2C9—digestive system—obesity	0.00102	0.0114	CbGeAlD
Epoprostenol—CYP2C9—endocrine gland—obesity	0.000844	0.00943	CbGeAlD
Epoprostenol—CYP2C9—liver—obesity	0.000761	0.0085	CbGeAlD
Epoprostenol—Dinoprostone—SLC22A1—obesity	0.000553	0.0483	CrCbGaD
Epoprostenol—Rash—Diethylpropion—obesity	0.000499	0.00145	CcSEcCtD
Epoprostenol—Dermatitis—Diethylpropion—obesity	0.000498	0.00145	CcSEcCtD
Epoprostenol—Dizziness—Cimetidine—obesity	0.000498	0.00145	CcSEcCtD
Epoprostenol—Haemoglobin—Bupropion—obesity	0.000496	0.00144	CcSEcCtD
Epoprostenol—Headache—Diethylpropion—obesity	0.000495	0.00144	CcSEcCtD
Epoprostenol—Rhinitis—Bupropion—obesity	0.000495	0.00144	CcSEcCtD
Epoprostenol—Haemorrhage—Bupropion—obesity	0.000493	0.00144	CcSEcCtD
Epoprostenol—Back pain—Orlistat—obesity	0.000492	0.00143	CcSEcCtD
Epoprostenol—Hypoaesthesia—Bupropion—obesity	0.000491	0.00143	CcSEcCtD
Epoprostenol—Pharyngitis—Bupropion—obesity	0.00049	0.00143	CcSEcCtD
Epoprostenol—Muscle spasms—Orlistat—obesity	0.000489	0.00143	CcSEcCtD
Epoprostenol—Oedema peripheral—Bupropion—obesity	0.000486	0.00142	CcSEcCtD
Epoprostenol—Flatulence—Sibutramine—obesity	0.000485	0.00141	CcSEcCtD
Epoprostenol—Connective tissue disorder—Bupropion—obesity	0.000485	0.00141	CcSEcCtD
Epoprostenol—Tension—Sibutramine—obesity	0.000483	0.00141	CcSEcCtD
Epoprostenol—Nervousness—Sibutramine—obesity	0.000478	0.00139	CcSEcCtD
Epoprostenol—Vomiting—Cimetidine—obesity	0.000478	0.00139	CcSEcCtD
Epoprostenol—Thirst—Topiramate—obesity	0.000477	0.00139	CcSEcCtD
Epoprostenol—Back pain—Sibutramine—obesity	0.000477	0.00139	CcSEcCtD
Epoprostenol—Rash—Cimetidine—obesity	0.000474	0.00138	CcSEcCtD
Epoprostenol—Dermatitis—Cimetidine—obesity	0.000474	0.00138	CcSEcCtD
Epoprostenol—Muscle spasms—Sibutramine—obesity	0.000474	0.00138	CcSEcCtD
Epoprostenol—Headache—Cimetidine—obesity	0.000471	0.00137	CcSEcCtD
Epoprostenol—Nausea—Diethylpropion—obesity	0.00047	0.00137	CcSEcCtD
Epoprostenol—Tremor—Sibutramine—obesity	0.000462	0.00134	CcSEcCtD
Epoprostenol—Cardiac disorder—Bupropion—obesity	0.000458	0.00133	CcSEcCtD
Epoprostenol—Flushing—Bupropion—obesity	0.000458	0.00133	CcSEcCtD
Epoprostenol—Anaemia—Sibutramine—obesity	0.000455	0.00133	CcSEcCtD
Epoprostenol—Agitation—Sibutramine—obesity	0.000453	0.00132	CcSEcCtD
Epoprostenol—Palpitations—Orlistat—obesity	0.00045	0.00131	CcSEcCtD
Epoprostenol—Angiopathy—Bupropion—obesity	0.000448	0.0013	CcSEcCtD
Epoprostenol—Nausea—Cimetidine—obesity	0.000447	0.0013	CcSEcCtD
Epoprostenol—Mediastinal disorder—Bupropion—obesity	0.000445	0.00129	CcSEcCtD
Epoprostenol—Cough—Orlistat—obesity	0.000444	0.00129	CcSEcCtD
Epoprostenol—Chills—Bupropion—obesity	0.000443	0.00129	CcSEcCtD
Epoprostenol—Syncope—Sibutramine—obesity	0.000442	0.00129	CcSEcCtD
Epoprostenol—Palpitations—Sibutramine—obesity	0.000435	0.00127	CcSEcCtD
Epoprostenol—Myalgia—Orlistat—obesity	0.000433	0.00126	CcSEcCtD
Epoprostenol—Chest pain—Orlistat—obesity	0.000433	0.00126	CcSEcCtD
Epoprostenol—Loss of consciousness—Sibutramine—obesity	0.000433	0.00126	CcSEcCtD
Epoprostenol—Mental disorder—Bupropion—obesity	0.000432	0.00126	CcSEcCtD
Epoprostenol—Anxiety—Orlistat—obesity	0.000432	0.00126	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00043	0.00125	CcSEcCtD
Epoprostenol—Cough—Sibutramine—obesity	0.00043	0.00125	CcSEcCtD
Epoprostenol—Dry mouth—Orlistat—obesity	0.000424	0.00123	CcSEcCtD
Epoprostenol—Flatulence—Bupropion—obesity	0.000423	0.00123	CcSEcCtD
Epoprostenol—Tension—Bupropion—obesity	0.000421	0.00123	CcSEcCtD
Epoprostenol—Myalgia—Sibutramine—obesity	0.000419	0.00122	CcSEcCtD
Epoprostenol—Arthralgia—Sibutramine—obesity	0.000419	0.00122	CcSEcCtD
Epoprostenol—Chest pain—Sibutramine—obesity	0.000419	0.00122	CcSEcCtD
Epoprostenol—Anxiety—Sibutramine—obesity	0.000418	0.00122	CcSEcCtD
Epoprostenol—Nervousness—Bupropion—obesity	0.000417	0.00121	CcSEcCtD
Epoprostenol—Oedema—Orlistat—obesity	0.000415	0.00121	CcSEcCtD
Epoprostenol—Anaphylactic shock—Orlistat—obesity	0.000415	0.00121	CcSEcCtD
Epoprostenol—Back pain—Bupropion—obesity	0.000415	0.00121	CcSEcCtD
Epoprostenol—Orthostatic hypotension—Topiramate—obesity	0.000415	0.00121	CcSEcCtD
Epoprostenol—Muscle spasms—Bupropion—obesity	0.000413	0.0012	CcSEcCtD
Epoprostenol—Infection—Orlistat—obesity	0.000413	0.0012	CcSEcCtD
Epoprostenol—Dinoprostone—CYP19A1—obesity	0.000411	0.0359	CrCbGaD
Epoprostenol—Dry mouth—Sibutramine—obesity	0.00041	0.00119	CcSEcCtD
Epoprostenol—Nervous system disorder—Orlistat—obesity	0.000407	0.00119	CcSEcCtD
Epoprostenol—Confusional state—Sibutramine—obesity	0.000405	0.00118	CcSEcCtD
Epoprostenol—Skin disorder—Orlistat—obesity	0.000404	0.00118	CcSEcCtD
Epoprostenol—Tremor—Bupropion—obesity	0.000402	0.00117	CcSEcCtD
Epoprostenol—Gastritis—Topiramate—obesity	0.000402	0.00117	CcSEcCtD
Epoprostenol—Anaphylactic shock—Sibutramine—obesity	0.000402	0.00117	CcSEcCtD
Epoprostenol—Oedema—Sibutramine—obesity	0.000402	0.00117	CcSEcCtD
Epoprostenol—Hyperhidrosis—Orlistat—obesity	0.000402	0.00117	CcSEcCtD
Epoprostenol—Infection—Sibutramine—obesity	0.000399	0.00116	CcSEcCtD
Epoprostenol—Anaemia—Bupropion—obesity	0.000397	0.00116	CcSEcCtD
Epoprostenol—Shock—Sibutramine—obesity	0.000396	0.00115	CcSEcCtD
Epoprostenol—Abdominal distension—Topiramate—obesity	0.000395	0.00115	CcSEcCtD
Epoprostenol—Agitation—Bupropion—obesity	0.000395	0.00115	CcSEcCtD
Epoprostenol—Thrombocytopenia—Sibutramine—obesity	0.000394	0.00115	CcSEcCtD
Epoprostenol—Tachycardia—Sibutramine—obesity	0.000392	0.00114	CcSEcCtD
Epoprostenol—Skin disorder—Sibutramine—obesity	0.000391	0.00114	CcSEcCtD
Epoprostenol—Hyperhidrosis—Sibutramine—obesity	0.000389	0.00113	CcSEcCtD
Epoprostenol—Syncope—Bupropion—obesity	0.000385	0.00112	CcSEcCtD
Epoprostenol—Anorexia—Sibutramine—obesity	0.000383	0.00112	CcSEcCtD
Epoprostenol—Palpitations—Bupropion—obesity	0.00038	0.00111	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Orlistat—obesity	0.000379	0.0011	CcSEcCtD
Epoprostenol—Loss of consciousness—Bupropion—obesity	0.000377	0.0011	CcSEcCtD
Epoprostenol—Abdominal discomfort—Topiramate—obesity	0.000376	0.0011	CcSEcCtD
Epoprostenol—Insomnia—Orlistat—obesity	0.000376	0.00109	CcSEcCtD
Epoprostenol—Hypotension—Sibutramine—obesity	0.000376	0.00109	CcSEcCtD
Epoprostenol—Cough—Bupropion—obesity	0.000375	0.00109	CcSEcCtD
Epoprostenol—Paraesthesia—Orlistat—obesity	0.000373	0.00109	CcSEcCtD
Epoprostenol—Pancytopenia—Topiramate—obesity	0.000373	0.00109	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Sibutramine—obesity	0.000366	0.00107	CcSEcCtD
Epoprostenol—Dyspepsia—Orlistat—obesity	0.000366	0.00106	CcSEcCtD
Epoprostenol—Chest pain—Bupropion—obesity	0.000366	0.00106	CcSEcCtD
Epoprostenol—Arthralgia—Bupropion—obesity	0.000366	0.00106	CcSEcCtD
Epoprostenol—Myalgia—Bupropion—obesity	0.000366	0.00106	CcSEcCtD
Epoprostenol—Anxiety—Bupropion—obesity	0.000364	0.00106	CcSEcCtD
Epoprostenol—Insomnia—Sibutramine—obesity	0.000364	0.00106	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000363	0.00106	CcSEcCtD
Epoprostenol—Decreased appetite—Orlistat—obesity	0.000361	0.00105	CcSEcCtD
Epoprostenol—Paraesthesia—Sibutramine—obesity	0.000361	0.00105	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Orlistat—obesity	0.000359	0.00104	CcSEcCtD
Epoprostenol—Dyspnoea—Sibutramine—obesity	0.000358	0.00104	CcSEcCtD
Epoprostenol—Fatigue—Orlistat—obesity	0.000358	0.00104	CcSEcCtD
Epoprostenol—Dry mouth—Bupropion—obesity	0.000358	0.00104	CcSEcCtD
Epoprostenol—Somnolence—Sibutramine—obesity	0.000357	0.00104	CcSEcCtD
Epoprostenol—Weight decreased—Topiramate—obesity	0.000355	0.00103	CcSEcCtD
Epoprostenol—Pain—Orlistat—obesity	0.000355	0.00103	CcSEcCtD
Epoprostenol—Dyspepsia—Sibutramine—obesity	0.000354	0.00103	CcSEcCtD
Epoprostenol—Confusional state—Bupropion—obesity	0.000353	0.00103	CcSEcCtD
Epoprostenol—Pneumonia—Topiramate—obesity	0.000352	0.00103	CcSEcCtD
Epoprostenol—Anaphylactic shock—Bupropion—obesity	0.000351	0.00102	CcSEcCtD
Epoprostenol—Oedema—Bupropion—obesity	0.000351	0.00102	CcSEcCtD
Epoprostenol—Infestation NOS—Topiramate—obesity	0.00035	0.00102	CcSEcCtD
Epoprostenol—Infestation—Topiramate—obesity	0.00035	0.00102	CcSEcCtD
Epoprostenol—Decreased appetite—Sibutramine—obesity	0.00035	0.00102	CcSEcCtD
Epoprostenol—Depression—Topiramate—obesity	0.000349	0.00102	CcSEcCtD
Epoprostenol—Infection—Bupropion—obesity	0.000348	0.00101	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Sibutramine—obesity	0.000347	0.00101	CcSEcCtD
Epoprostenol—Shock—Bupropion—obesity	0.000345	0.001	CcSEcCtD
Epoprostenol—Constipation—Sibutramine—obesity	0.000344	0.001	CcSEcCtD
Epoprostenol—Pain—Sibutramine—obesity	0.000344	0.001	CcSEcCtD
Epoprostenol—Nervous system disorder—Bupropion—obesity	0.000344	0.001	CcSEcCtD
Epoprostenol—Thrombocytopenia—Bupropion—obesity	0.000343	0.000999	CcSEcCtD
Epoprostenol—Tachycardia—Bupropion—obesity	0.000342	0.000996	CcSEcCtD
Epoprostenol—Skin disorder—Bupropion—obesity	0.00034	0.000991	CcSEcCtD
Epoprostenol—Urinary tract infection—Topiramate—obesity	0.00034	0.000991	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Orlistat—obesity	0.00034	0.000989	CcSEcCtD
Epoprostenol—Hyperhidrosis—Bupropion—obesity	0.000339	0.000987	CcSEcCtD
Epoprostenol—Anorexia—Bupropion—obesity	0.000334	0.000973	CcSEcCtD
Epoprostenol—Haematuria—Topiramate—obesity	0.000334	0.000972	CcSEcCtD
Epoprostenol—Epistaxis—Topiramate—obesity	0.00033	0.000962	CcSEcCtD
Epoprostenol—Urticaria—Orlistat—obesity	0.00033	0.000961	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Sibutramine—obesity	0.000329	0.000957	CcSEcCtD
Epoprostenol—Sinusitis—Topiramate—obesity	0.000328	0.000957	CcSEcCtD
Epoprostenol—Abdominal pain—Orlistat—obesity	0.000328	0.000956	CcSEcCtD
Epoprostenol—Body temperature increased—Orlistat—obesity	0.000328	0.000956	CcSEcCtD
Epoprostenol—Hypotension—Bupropion—obesity	0.000328	0.000954	CcSEcCtD
Epoprostenol—Bradycardia—Topiramate—obesity	0.00032	0.000932	CcSEcCtD
Epoprostenol—Urticaria—Sibutramine—obesity	0.000319	0.00093	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Bupropion—obesity	0.000319	0.00093	CcSEcCtD
Epoprostenol—Body temperature increased—Sibutramine—obesity	0.000318	0.000926	CcSEcCtD
Epoprostenol—Abdominal pain—Sibutramine—obesity	0.000318	0.000926	CcSEcCtD
Epoprostenol—Insomnia—Bupropion—obesity	0.000317	0.000923	CcSEcCtD
Epoprostenol—Haemoglobin—Topiramate—obesity	0.000316	0.00092	CcSEcCtD
Epoprostenol—Rhinitis—Topiramate—obesity	0.000315	0.000918	CcSEcCtD
Epoprostenol—Paraesthesia—Bupropion—obesity	0.000315	0.000917	CcSEcCtD
Epoprostenol—Haemorrhage—Topiramate—obesity	0.000314	0.000915	CcSEcCtD
Epoprostenol—Hypoaesthesia—Topiramate—obesity	0.000313	0.000911	CcSEcCtD
Epoprostenol—Dyspnoea—Bupropion—obesity	0.000312	0.00091	CcSEcCtD
Epoprostenol—Pharyngitis—Topiramate—obesity	0.000312	0.000908	CcSEcCtD
Epoprostenol—Somnolence—Bupropion—obesity	0.000312	0.000907	CcSEcCtD
Epoprostenol—Oedema peripheral—Topiramate—obesity	0.00031	0.000902	CcSEcCtD
Epoprostenol—Connective tissue disorder—Topiramate—obesity	0.000309	0.000899	CcSEcCtD
Epoprostenol—Dyspepsia—Bupropion—obesity	0.000309	0.000898	CcSEcCtD
Epoprostenol—Hypersensitivity—Orlistat—obesity	0.000306	0.000891	CcSEcCtD
Epoprostenol—Decreased appetite—Bupropion—obesity	0.000305	0.000887	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Bupropion—obesity	0.000303	0.000881	CcSEcCtD
Epoprostenol—Fatigue—Bupropion—obesity	0.000302	0.00088	CcSEcCtD
Epoprostenol—Constipation—Bupropion—obesity	0.0003	0.000873	CcSEcCtD
Epoprostenol—Pain—Bupropion—obesity	0.0003	0.000873	CcSEcCtD
Epoprostenol—Asthenia—Orlistat—obesity	0.000298	0.000868	CcSEcCtD
Epoprostenol—Hypersensitivity—Sibutramine—obesity	0.000296	0.000863	CcSEcCtD
Epoprostenol—Pruritus—Orlistat—obesity	0.000294	0.000856	CcSEcCtD
Epoprostenol—Flushing—Topiramate—obesity	0.000292	0.000849	CcSEcCtD
Epoprostenol—Cardiac disorder—Topiramate—obesity	0.000292	0.000849	CcSEcCtD
Epoprostenol—Asthenia—Sibutramine—obesity	0.000288	0.00084	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Bupropion—obesity	0.000287	0.000835	CcSEcCtD
Epoprostenol—Angiopathy—Topiramate—obesity	0.000285	0.00083	CcSEcCtD
Epoprostenol—Pruritus—Sibutramine—obesity	0.000284	0.000828	CcSEcCtD
Epoprostenol—Diarrhoea—Orlistat—obesity	0.000284	0.000828	CcSEcCtD
Epoprostenol—Mediastinal disorder—Topiramate—obesity	0.000283	0.000825	CcSEcCtD
Epoprostenol—Chills—Topiramate—obesity	0.000282	0.000821	CcSEcCtD
Epoprostenol—Urticaria—Bupropion—obesity	0.000278	0.000811	CcSEcCtD
Epoprostenol—Abdominal pain—Bupropion—obesity	0.000277	0.000807	CcSEcCtD
Epoprostenol—Body temperature increased—Bupropion—obesity	0.000277	0.000807	CcSEcCtD
Epoprostenol—Mental disorder—Topiramate—obesity	0.000275	0.000802	CcSEcCtD
Epoprostenol—Diarrhoea—Sibutramine—obesity	0.000275	0.000801	CcSEcCtD
Epoprostenol—Dizziness—Orlistat—obesity	0.000275	0.0008	CcSEcCtD
Epoprostenol—Flatulence—Topiramate—obesity	0.00027	0.000785	CcSEcCtD
Epoprostenol—Tension—Topiramate—obesity	0.000269	0.000782	CcSEcCtD
Epoprostenol—Dizziness—Sibutramine—obesity	0.000266	0.000774	CcSEcCtD
Epoprostenol—Nervousness—Topiramate—obesity	0.000266	0.000774	CcSEcCtD
Epoprostenol—Back pain—Topiramate—obesity	0.000265	0.000771	CcSEcCtD
Epoprostenol—Vomiting—Orlistat—obesity	0.000264	0.000769	CcSEcCtD
Epoprostenol—Muscle spasms—Topiramate—obesity	0.000263	0.000766	CcSEcCtD
Epoprostenol—Rash—Orlistat—obesity	0.000262	0.000763	CcSEcCtD
Epoprostenol—Dermatitis—Orlistat—obesity	0.000262	0.000762	CcSEcCtD
Epoprostenol—Headache—Orlistat—obesity	0.00026	0.000758	CcSEcCtD
Epoprostenol—Hypersensitivity—Bupropion—obesity	0.000258	0.000752	CcSEcCtD
Epoprostenol—Tremor—Topiramate—obesity	0.000256	0.000747	CcSEcCtD
Epoprostenol—Vomiting—Sibutramine—obesity	0.000256	0.000744	CcSEcCtD
Epoprostenol—Rash—Sibutramine—obesity	0.000254	0.000738	CcSEcCtD
Epoprostenol—Dermatitis—Sibutramine—obesity	0.000253	0.000738	CcSEcCtD
Epoprostenol—Anaemia—Topiramate—obesity	0.000253	0.000736	CcSEcCtD
Epoprostenol—Headache—Sibutramine—obesity	0.000252	0.000733	CcSEcCtD
Epoprostenol—Asthenia—Bupropion—obesity	0.000251	0.000732	CcSEcCtD
Epoprostenol—Agitation—Topiramate—obesity	0.000251	0.000732	CcSEcCtD
Epoprostenol—Pruritus—Bupropion—obesity	0.000248	0.000722	CcSEcCtD
Epoprostenol—Nausea—Orlistat—obesity	0.000247	0.000719	CcSEcCtD
Epoprostenol—Syncope—Topiramate—obesity	0.000245	0.000715	CcSEcCtD
Epoprostenol—Palpitations—Topiramate—obesity	0.000242	0.000704	CcSEcCtD
Epoprostenol—Loss of consciousness—Topiramate—obesity	0.00024	0.0007	CcSEcCtD
Epoprostenol—Diarrhoea—Bupropion—obesity	0.00024	0.000698	CcSEcCtD
Epoprostenol—Nausea—Sibutramine—obesity	0.000239	0.000695	CcSEcCtD
Epoprostenol—Cough—Topiramate—obesity	0.000239	0.000695	CcSEcCtD
Epoprostenol—Arthralgia—Topiramate—obesity	0.000233	0.000678	CcSEcCtD
Epoprostenol—Chest pain—Topiramate—obesity	0.000233	0.000678	CcSEcCtD
Epoprostenol—Myalgia—Topiramate—obesity	0.000233	0.000678	CcSEcCtD
Epoprostenol—Anxiety—Topiramate—obesity	0.000232	0.000676	CcSEcCtD
Epoprostenol—Dizziness—Bupropion—obesity	0.000232	0.000675	CcSEcCtD
Epoprostenol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000231	0.000674	CcSEcCtD
Epoprostenol—Dry mouth—Topiramate—obesity	0.000228	0.000663	CcSEcCtD
Epoprostenol—Confusional state—Topiramate—obesity	0.000225	0.000656	CcSEcCtD
Epoprostenol—Oedema—Topiramate—obesity	0.000223	0.00065	CcSEcCtD
Epoprostenol—Vomiting—Bupropion—obesity	0.000223	0.000649	CcSEcCtD
Epoprostenol—Infection—Topiramate—obesity	0.000222	0.000646	CcSEcCtD
Epoprostenol—Rash—Bupropion—obesity	0.000221	0.000644	CcSEcCtD
Epoprostenol—Dermatitis—Bupropion—obesity	0.000221	0.000643	CcSEcCtD
Epoprostenol—Shock—Topiramate—obesity	0.00022	0.00064	CcSEcCtD
Epoprostenol—Headache—Bupropion—obesity	0.00022	0.000639	CcSEcCtD
Epoprostenol—Nervous system disorder—Topiramate—obesity	0.000219	0.000638	CcSEcCtD
Epoprostenol—Thrombocytopenia—Topiramate—obesity	0.000219	0.000637	CcSEcCtD
Epoprostenol—Tachycardia—Topiramate—obesity	0.000218	0.000635	CcSEcCtD
Epoprostenol—Skin disorder—Topiramate—obesity	0.000217	0.000632	CcSEcCtD
Epoprostenol—Hyperhidrosis—Topiramate—obesity	0.000216	0.000629	CcSEcCtD
Epoprostenol—Anorexia—Topiramate—obesity	0.000213	0.00062	CcSEcCtD
Epoprostenol—Hypotension—Topiramate—obesity	0.000209	0.000608	CcSEcCtD
Epoprostenol—Nausea—Bupropion—obesity	0.000208	0.000606	CcSEcCtD
Epoprostenol—Musculoskeletal discomfort—Topiramate—obesity	0.000203	0.000592	CcSEcCtD
Epoprostenol—Insomnia—Topiramate—obesity	0.000202	0.000588	CcSEcCtD
Epoprostenol—Paraesthesia—Topiramate—obesity	0.000201	0.000584	CcSEcCtD
Epoprostenol—Dyspnoea—Topiramate—obesity	0.000199	0.00058	CcSEcCtD
Epoprostenol—Somnolence—Topiramate—obesity	0.000199	0.000578	CcSEcCtD
Epoprostenol—Dyspepsia—Topiramate—obesity	0.000197	0.000572	CcSEcCtD
Epoprostenol—Decreased appetite—Topiramate—obesity	0.000194	0.000565	CcSEcCtD
Epoprostenol—Gastrointestinal disorder—Topiramate—obesity	0.000193	0.000561	CcSEcCtD
Epoprostenol—Fatigue—Topiramate—obesity	0.000193	0.000561	CcSEcCtD
Epoprostenol—Constipation—Topiramate—obesity	0.000191	0.000556	CcSEcCtD
Epoprostenol—Pain—Topiramate—obesity	0.000191	0.000556	CcSEcCtD
Epoprostenol—Gastrointestinal pain—Topiramate—obesity	0.000183	0.000532	CcSEcCtD
Epoprostenol—Urticaria—Topiramate—obesity	0.000177	0.000517	CcSEcCtD
Epoprostenol—Abdominal pain—Topiramate—obesity	0.000177	0.000514	CcSEcCtD
Epoprostenol—Body temperature increased—Topiramate—obesity	0.000177	0.000514	CcSEcCtD
Epoprostenol—Hypersensitivity—Topiramate—obesity	0.000165	0.000479	CcSEcCtD
Epoprostenol—Asthenia—Topiramate—obesity	0.00016	0.000467	CcSEcCtD
Epoprostenol—Pruritus—Topiramate—obesity	0.000158	0.00046	CcSEcCtD
Epoprostenol—Diarrhoea—Topiramate—obesity	0.000153	0.000445	CcSEcCtD
Epoprostenol—Dizziness—Topiramate—obesity	0.000148	0.00043	CcSEcCtD
Epoprostenol—Vomiting—Topiramate—obesity	0.000142	0.000413	CcSEcCtD
Epoprostenol—Rash—Topiramate—obesity	0.000141	0.00041	CcSEcCtD
Epoprostenol—Dermatitis—Topiramate—obesity	0.000141	0.00041	CcSEcCtD
Epoprostenol—Headache—Topiramate—obesity	0.00014	0.000407	CcSEcCtD
Epoprostenol—Nausea—Topiramate—obesity	0.000133	0.000386	CcSEcCtD
Epoprostenol—P2RY12—Signaling Pathways—APOE—obesity	2.26e-05	6.94e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYB5A—obesity	2.26e-05	6.93e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—DGAT1—obesity	2.26e-05	6.93e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CAV1—obesity	2.24e-05	6.88e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—HTR2A—obesity	2.24e-05	6.87e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—HTR2A—obesity	2.24e-05	6.87e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—C3—obesity	2.24e-05	6.87e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—C3—obesity	2.24e-05	6.87e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—APOA1—obesity	2.24e-05	6.87e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—obesity	2.23e-05	6.84e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ACLY—obesity	2.18e-05	6.67e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—STAT3—obesity	2.17e-05	6.66e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—obesity	2.17e-05	6.64e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—ESR1—obesity	2.16e-05	6.63e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—F2—obesity	2.14e-05	6.55e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PRKCB—obesity	2.14e-05	6.55e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IRS2—obesity	2.13e-05	6.53e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IRS2—obesity	2.13e-05	6.53e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AGT—obesity	2.13e-05	6.52e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AGT—obesity	2.13e-05	6.52e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Hemostasis—AKT1—obesity	2.12e-05	6.49e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—BAD—obesity	2.11e-05	6.47e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ENPP1—obesity	2.1e-05	6.44e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALOX12—obesity	2.1e-05	6.44e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—LEP—obesity	2.08e-05	6.39e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—APOE—obesity	2.08e-05	6.39e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—APOE—obesity	2.08e-05	6.39e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—LEP—obesity	2.08e-05	6.39e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CAV1—obesity	2.06e-05	6.33e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CAV1—obesity	2.06e-05	6.33e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—FASN—obesity	2.06e-05	6.32e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—APOA1—obesity	2.06e-05	6.32e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—APOA1—obesity	2.06e-05	6.32e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—obesity	2.05e-05	6.3e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PIK3CG—obesity	2.04e-05	6.27e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HMGCS1—obesity	2.04e-05	6.24e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IRS1—obesity	2.02e-05	6.2e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—MYC—obesity	2.02e-05	6.19e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—TGFB1—obesity	2.01e-05	6.18e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—ESR1—obesity	1.99e-05	6.1e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—ESR1—obesity	1.99e-05	6.1e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PLIN1—obesity	1.98e-05	6.06e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ANGPTL4—obesity	1.98e-05	6.06e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ACADM—obesity	1.98e-05	6.06e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PNPLA2—obesity	1.98e-05	6.06e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SAT1—obesity	1.98e-05	6.06e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PFKFB3—obesity	1.98e-05	6.06e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—F2—obesity	1.97e-05	6.03e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—F2—obesity	1.97e-05	6.03e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PRKCB—obesity	1.97e-05	6.03e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PRKCB—obesity	1.97e-05	6.03e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—POMC—obesity	1.95e-05	5.97e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—BAD—obesity	1.94e-05	5.96e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—BAD—obesity	1.94e-05	5.96e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—INS—obesity	1.93e-05	5.93e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYTB—obesity	1.92e-05	5.89e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ACACB—obesity	1.92e-05	5.89e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—OXCT1—obesity	1.92e-05	5.89e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—CCL2—obesity	1.9e-05	5.84e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PIK3CG—obesity	1.88e-05	5.77e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PIK3CG—obesity	1.88e-05	5.77e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PNLIP—obesity	1.87e-05	5.74e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SRD5A1—obesity	1.87e-05	5.74e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IGF1—obesity	1.87e-05	5.74e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AKT2—obesity	1.87e-05	5.73e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IRS1—obesity	1.86e-05	5.7e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IRS1—obesity	1.86e-05	5.7e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SDC3—obesity	1.83e-05	5.61e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—obesity	1.82e-05	5.58e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PIK3CD—obesity	1.8e-05	5.51e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—NCOA1—obesity	1.79e-05	5.5e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—POMC—obesity	1.79e-05	5.49e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—POMC—obesity	1.79e-05	5.49e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP26B1—obesity	1.79e-05	5.48e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—STS—obesity	1.79e-05	5.48e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HK2—obesity	1.79e-05	5.48e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—INS—obesity	1.78e-05	5.46e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—INS—obesity	1.78e-05	5.46e-05	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—PIK3CA—obesity	1.78e-05	5.46e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—SERPINE1—obesity	1.78e-05	5.45e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—obesity	1.77e-05	5.42e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—CCL2—obesity	1.75e-05	5.37e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—CCL2—obesity	1.75e-05	5.37e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPARD—obesity	1.75e-05	5.36e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TYK2—obesity	1.73e-05	5.3e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IGF1—obesity	1.72e-05	5.28e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IGF1—obesity	1.72e-05	5.28e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AKT2—obesity	1.72e-05	5.28e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AKT2—obesity	1.72e-05	5.28e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—RHOA—obesity	1.71e-05	5.26e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—PIK3CA—obesity	1.71e-05	5.26e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SLC27A1—obesity	1.71e-05	5.25e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—NOS3—obesity	1.7e-05	5.2e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PIK3R1—obesity	1.7e-05	5.2e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GLUL—obesity	1.68e-05	5.15e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—FABP4—obesity	1.68e-05	5.15e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PIK3CD—obesity	1.65e-05	5.07e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PIK3CD—obesity	1.65e-05	5.07e-05	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—PIK3CA—obesity	1.64e-05	5.02e-05	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—PIK3CA—obesity	1.64e-05	5.02e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—SERPINE1—obesity	1.64e-05	5.02e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—SERPINE1—obesity	1.64e-05	5.02e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	1.62e-05	4.96e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—PIK3CA—obesity	1.62e-05	4.96e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ECHS1—obesity	1.59e-05	4.88e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—UCP2—obesity	1.59e-05	4.88e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HSD11B1—obesity	1.59e-05	4.88e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—UCP3—obesity	1.59e-05	4.88e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TYK2—obesity	1.59e-05	4.88e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TYK2—obesity	1.59e-05	4.88e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—RHOA—obesity	1.58e-05	4.84e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—RHOA—obesity	1.58e-05	4.84e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ADH1B—obesity	1.57e-05	4.8e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PIK3CB—obesity	1.57e-05	4.8e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MTOR—obesity	1.57e-05	4.8e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PIK3R1—obesity	1.56e-05	4.79e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PIK3R1—obesity	1.56e-05	4.79e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—NOS3—obesity	1.56e-05	4.79e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—NOS3—obesity	1.56e-05	4.79e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—APOB—obesity	1.54e-05	4.73e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPARGC1B—obesity	1.54e-05	4.73e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GPAM—obesity	1.54e-05	4.73e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ACSL1—obesity	1.54e-05	4.73e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—IL6—obesity	1.52e-05	4.65e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HADH—obesity	1.5e-05	4.59e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PCK1—obesity	1.5e-05	4.59e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—FADS1—obesity	1.5e-05	4.59e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—PIK3CA—obesity	1.49e-05	4.56e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—PIK3CA—obesity	1.49e-05	4.56e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—LPL—obesity	1.47e-05	4.52e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ACP5—obesity	1.46e-05	4.47e-05	CbGpPWpGaD
Epoprostenol—P2RY12—GPCR downstream signaling—AKT1—obesity	1.45e-05	4.46e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MTOR—obesity	1.44e-05	4.42e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PIK3CB—obesity	1.44e-05	4.42e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MTOR—obesity	1.44e-05	4.42e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PIK3CB—obesity	1.44e-05	4.42e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—obesity	1.44e-05	4.41e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—PIK3CA—obesity	1.44e-05	4.4e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—IL6—obesity	1.43e-05	4.39e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—G6PD—obesity	1.42e-05	4.35e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HK1—obesity	1.4e-05	4.3e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SREBF2—obesity	1.4e-05	4.3e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CD36—obesity	1.4e-05	4.29e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Disease—AKT1—obesity	1.4e-05	4.29e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MMP9—obesity	1.36e-05	4.17e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—LPA—obesity	1.35e-05	4.15e-05	CbGpPWpGaD
Epoprostenol—PTGIR—GPCR downstream signaling—AKT1—obesity	1.34e-05	4.1e-05	CbGpPWpGaD
Epoprostenol—PTGER1—GPCR downstream signaling—AKT1—obesity	1.34e-05	4.1e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—LPIN1—obesity	1.33e-05	4.06e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MAPK8—obesity	1.32e-05	4.06e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling by GPCR—AKT1—obesity	1.32e-05	4.05e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—IL6—obesity	1.32e-05	4.04e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—IL6—obesity	1.32e-05	4.04e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—obesity	1.3e-05	3.99e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—APOA5—obesity	1.3e-05	3.98e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—AGT—obesity	1.26e-05	3.87e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MMP9—obesity	1.25e-05	3.84e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MMP9—obesity	1.25e-05	3.84e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SLC22A1—obesity	1.24e-05	3.8e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CLOCK—obesity	1.24e-05	3.8e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—APOE—obesity	1.24e-05	3.79e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—obesity	1.22e-05	3.75e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—obesity	1.22e-05	3.75e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MAPK8—obesity	1.22e-05	3.74e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MAPK8—obesity	1.22e-05	3.74e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling by GPCR—AKT1—obesity	1.21e-05	3.73e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling by GPCR—AKT1—obesity	1.21e-05	3.73e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—STAT3—obesity	1.21e-05	3.71e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SULT2A1—obesity	1.21e-05	3.7e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GLP1R—obesity	1.21e-05	3.7e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—DPYD—obesity	1.19e-05	3.64e-05	CbGpPWpGaD
Epoprostenol—PTGIS—Metabolism—AKT1—obesity	1.17e-05	3.6e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PRKAR2B—obesity	1.14e-05	3.51e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—DCN—obesity	1.13e-05	3.48e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—MYC—obesity	1.12e-05	3.45e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—TGFB1—obesity	1.12e-05	3.44e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—obesity	1.12e-05	3.42e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—STAT3—obesity	1.11e-05	3.42e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—STAT3—obesity	1.11e-05	3.42e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CPT1A—obesity	1.1e-05	3.39e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NAMPT—obesity	1.08e-05	3.32e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—obesity	1.08e-05	3.3e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—LIPC—obesity	1.08e-05	3.3e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GCK—obesity	1.08e-05	3.3e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—APOC3—obesity	1.07e-05	3.28e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—POMC—obesity	1.06e-05	3.25e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CETP—obesity	1.04e-05	3.18e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—MYC—obesity	1.03e-05	3.17e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—MYC—obesity	1.03e-05	3.17e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—TGFB1—obesity	1.03e-05	3.17e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—TGFB1—obesity	1.03e-05	3.17e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SDC1—obesity	1.03e-05	3.15e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AKR1C3—obesity	1.01e-05	3.1e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SCARB1—obesity	9.94e-06	3.05e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—obesity	9.8e-06	3.01e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—obesity	9.68e-06	2.97e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SREBF1—obesity	9.65e-06	2.96e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—PIK3CA—obesity	9.55e-06	2.93e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GOT2—obesity	9.39e-06	2.88e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—obesity	9.26e-06	2.84e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—FASN—obesity	9.18e-06	2.82e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—BCHE—obesity	9.15e-06	2.8e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP2E1—obesity	8.82e-06	2.71e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—PIK3CA—obesity	8.79e-06	2.69e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—PIK3CA—obesity	8.79e-06	2.69e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NQO1—obesity	8.73e-06	2.68e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	8.54e-06	2.62e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	8.47e-06	2.6e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—IL6—obesity	8.45e-06	2.59e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GCG—obesity	8.37e-06	2.57e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—SLC2A4—obesity	8.37e-06	2.57e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYCS—obesity	8.26e-06	2.53e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GGT1—obesity	8.1e-06	2.48e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GOT1—obesity	8.1e-06	2.48e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NCOA1—obesity	7.98e-06	2.45e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—STK11—obesity	7.86e-06	2.41e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CYP19A1—obesity	7.86e-06	2.41e-05	CbGpPWpGaD
Epoprostenol—P2RY12—Signaling Pathways—AKT1—obesity	7.8e-06	2.39e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—IL6—obesity	7.78e-06	2.39e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—IL6—obesity	7.78e-06	2.39e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—COMT—obesity	7.31e-06	2.24e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GNB3—obesity	7.21e-06	2.21e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPARGC1A—obesity	7.21e-06	2.21e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—HMOX1—obesity	7.18e-06	2.2e-05	CbGpPWpGaD
Epoprostenol—PTGER1—Signaling Pathways—AKT1—obesity	7.18e-06	2.2e-05	CbGpPWpGaD
Epoprostenol—PTGIR—Signaling Pathways—AKT1—obesity	7.18e-06	2.2e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GNAS—obesity	7.02e-06	2.15e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—APOB—obesity	6.87e-06	2.11e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—LPL—obesity	6.56e-06	2.01e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—GPX1—obesity	6.4e-06	1.96e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CD36—obesity	6.24e-06	1.91e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—MTHFR—obesity	5.91e-06	1.81e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPARA—obesity	5.8e-06	1.78e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AGT—obesity	5.62e-06	1.72e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—APOE—obesity	5.5e-06	1.69e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—CAV1—obesity	5.45e-06	1.67e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—APOA1—obesity	5.44e-06	1.67e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	5.21e-06	1.6e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PIK3CG—obesity	4.97e-06	1.52e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PPARG—obesity	4.79e-06	1.47e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—POMC—obesity	4.73e-06	1.45e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—INS—obesity	4.7e-06	1.44e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PIK3CD—obesity	4.37e-06	1.34e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—ALB—obesity	4.31e-06	1.32e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PIK3R1—obesity	4.12e-06	1.26e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—NOS3—obesity	4.12e-06	1.26e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PIK3CB—obesity	3.8e-06	1.17e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PTGS2—obesity	3.77e-06	1.16e-05	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—PIK3CA—obesity	2.32e-06	7.11e-06	CbGpPWpGaD
Epoprostenol—CYP2C9—Metabolism—AKT1—obesity	1.89e-06	5.81e-06	CbGpPWpGaD
